Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac

Completed

• Conditions: Vaccination

• Registration Number: NCT00450554
• Lead Sponsor: University Hospital, Rouen

Brief Summary

The main objective of the study is to estimate the proportion of children, born between the 01/01/2002 and the 06/23/200, living around Dieppe (cantons Dieppe est, Dieppe Ouest and Offranville), vaccinated by MenBVac, with a serum bactericidal activity against B:14,P1-7,16 clone related to a protection (\>= 4), before and after the third MenBvac vaccination.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-02
• Study First Submitted: 2007-03-19
• Study First Submitted QC: 2007-03-21
• Study First Posted: 2007-03-22
• Primary Completion: 2008-05
• Study Completion: 2008-05
• Status Verified: 2012-03
• Last Update Submitted: 2012-03-26
• Last Update Posted: 2012-03-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 236

Inclusion Criteria

• children born between 01/01/2000 and 06/23/2005, living in Dieppe-Est, Dieppe-Ouest and Offranville, vaccinated twice by MenBVac
• parental authority(ies)assent

Exclusion Criteria

• no parental authority(ies)assent
• no blood sample during the third vaccination
• impossibility of third vaccination

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

UH-rouen; 🇫🇷 Rouen, Seine Maritime, France